Informing patients about phase I trials--how should it be done?

A retrospective analysis of phase I and phase I/II investigator-initiated clinical trials conducted by the Swiss Group for Clinical Cancer Research (SAKK).

ESMO open·2025

ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Challenges in oncology career: are we closing the gender gap? Results of the new ESMO Women for Oncology Committee survey.

ESMO open·2023

INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line.

British journal of cancer·2023

The impact of COVID-19 on cancer care and oncology clinical research: an experts' perspective.

ESMO open·2021

Female leadership in oncology-has progress stalled? Data from the ESMO W4O authorship and monitoring studies.

ESMO open·2021

Prognostic significance of isolated tumor cells and nodal tumor burden in endometrial cancer: a population-based cohort study.

Acta oncologica (Stockholm, Sweden)·2026

Improving cervical cancer screening uptake through theory-informed education: a comprehensive systematic review and meta-analysis.

Acta oncologica (Stockholm, Sweden)·2026

The Clinical outcomes following pencil beam scanning proton therapy for skull base chordoma and chondrosarcoma: a single-institution experience.

Acta oncologica (Stockholm, Sweden)·2026

User perceptions of machine learning models as decision support for colorectal cancer multidisciplinary team conferences (AID-SIM-2): a qualitative simulation study.

Acta oncologica (Stockholm, Sweden)·2026

Estimated number of children affected by paternal cancer diagnosis and death in Finland during 1970-2022: a population-based registry study.

Acta oncologica (Stockholm, Sweden)·2026

The impact of pazopanib and extremity radiotherapy on transaminase elevations in soft tissue sarcoma.

Acta oncologica (Stockholm, Sweden)·2026

Multi-omics dissection of FOXA1 reveals cancer-type-specific transcriptional networks and functional risk variants.

iScience·2026

The research progress of the synergistic effect of Epstein-Barr virus and Helicobacter pylori infection in the occurrence and development of gastric cancer.

Frontiers in oncology·2026

Global, regional, and national analysis of CNS cancers burden from 1990 to 2021 and forecast of disease trend over the next 25 years.

Medicine·2026

Ionizing Radiation and Ultraviolet Light Irradiation-Associated DNA Damage Increasing Genomic Instability Risk.

Cancer science·2026

Spatial analysis of head and neck cancer identifies two ecosystems with distinct modes of epithelial-to-mesenchymal transition.

Nature genetics·2026

Derivation of clinical subphenotypes of candidemia and their association with mortality: a nationwide multicentre retrospective cohort study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026

Related Experiment Videos

Informing patients about phase I trials--how should it be done?

Related Concept Videos

A retrospective analysis of phase I and phase I/II investigator-initiated clinical trials conducted by the Swiss Group for Clinical Cancer Research (SAKK).

ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.

Challenges in oncology career: are we closing the gender gap? Results of the new ESMO Women for Oncology Committee survey.

INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line.

The impact of COVID-19 on cancer care and oncology clinical research: an experts' perspective.

Female leadership in oncology-has progress stalled? Data from the ESMO W4O authorship and monitoring studies.

Prognostic significance of isolated tumor cells and nodal tumor burden in endometrial cancer: a population-based cohort study.

Improving cervical cancer screening uptake through theory-informed education: a comprehensive systematic review and meta-analysis.

The Clinical outcomes following pencil beam scanning proton therapy for skull base chordoma and chondrosarcoma: a single-institution experience.

User perceptions of machine learning models as decision support for colorectal cancer multidisciplinary team conferences (AID-SIM-2): a qualitative simulation study.

Estimated number of children affected by paternal cancer diagnosis and death in Finland during 1970-2022: a population-based registry study.

The impact of pazopanib and extremity radiotherapy on transaminase elevations in soft tissue sarcoma.

Multi-omics dissection of FOXA1 reveals cancer-type-specific transcriptional networks and functional risk variants.

The research progress of the synergistic effect of Epstein-Barr virus and Helicobacter pylori infection in the occurrence and development of gastric cancer.

Global, regional, and national analysis of CNS cancers burden from 1990 to 2021 and forecast of disease trend over the next 25 years.

Ionizing Radiation and Ultraviolet Light Irradiation-Associated DNA Damage Increasing Genomic Instability Risk.

Spatial analysis of head and neck cancer identifies two ecosystems with distinct modes of epithelial-to-mesenchymal transition.

Derivation of clinical subphenotypes of candidemia and their association with mortality: a nationwide multicentre retrospective cohort study.

Related Experiment Videos

Informing patients about phase I trials--how should it be done?

Related Concept Videos

Related Articles